Free Newsletter
SPOTLIGHT: Abbott hit with antitrust suit
Free newsletter via e-mail
Tools
Pharmacies and a wholesaler slapped Abbott Laboratories with an antitrust lawsuit over the price of its AIDS drug Norvir, which jumped 400 percent in 2003. Report
More stories about pharmacies
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: